Concepedia

Determinants of persistence with bisphosphonates: A study in women with postmenopausal osteoporosis

Fernie J. A. Penning‐van Beest, Wim Goettsch, Joëlle A. Erkens, Ron M. C. Herings

Clinical Therapeutics · 2006 · 144 citations · 9 references

DOI

Concepts

References

9

Osteoporosis Prevention, Diagnosis, and Therapy

JAMA · 2001 · 5.5K citations

, , +16

Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women

Henry G. Bone, David Hosking, Jean‐Pierre Devogelaer et al. · New England Journal of Medicine · 2004 · 1.4K citations · Full text

, , +13

Compliance with drug therapies for the treatment and prevention of osteoporosis

Jeffrey S. McCombs, Patrick Thiebaud, Connie McLaughlin-Miley et al. · Maturitas · 2004 · 353 citations

, , +12

Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: A multicenter, randomized, open-label, crossover study

James A. Simon, E. Michael Lewiecki, Mary E. Smith et al. · Clinical Therapeutics · 2002 · 171 citations

, , +7

Predictors of Long-term Persistence on Statins in a Subsidized Clinical Population

Vanessa S. Catalan, Jacques LeLorier · Value in Health · 2000 · 109 citations · Full text

, , +10